Cargando…
Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer’s disease through inhibition of inflammation
BACKGROUND: Alzheimer’s disease (AD) is a multifactorial disorder associated with the accumulation of soluble forms of beta-amyloid (Aβ) and its subsequent deposition into plaques. One of the major contributors to neuronal death is chronic and uncontrolled inflammatory activation of microglial cells...
Autores principales: | Malm, Tarja, Mariani, Monica, Donovan, Lauren J, Neilson, Lee, Landreth, Gary E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310027/ https://www.ncbi.nlm.nih.gov/pubmed/25592770 http://dx.doi.org/10.1186/s12974-014-0229-9 |
Ejemplares similares
-
Neuronally-directed effects of RXR activation in a mouse model of Alzheimer’s disease
por: Mariani, M. M., et al.
Publicado: (2017) -
Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer’s disease
por: Casali, Brad T., et al.
Publicado: (2018) -
Animal Models of Alzheimer’s Disease: Utilization of Transgenic Alzheimer’s Disease Models in Studies of Amyloid Beta Clearance
por: Malm, Tarja, et al.
Publicado: (2012) -
Neuroprotective Mechanisms of PPARδ: Modulation of Oxidative Stress and Inflammatory Processes
por: Schnegg, Caroline I., et al.
Publicado: (2011) -
PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)